Nucleotide-modified RNA-aptamer inhibits in vitro cell-proliferation of Burkitt lymphoma, but not B-cell lymphoblastoid or T-cell lymphoma cell lines

I. Kholodnyuk; Z. Rudevica; M. Cistjakovs; S. Kozireva; G. Norstedt; A. Leonciks

Nucleotide-modified RNA-aptamer inhibits in vitro cell-proliferation of Burkitt lymphoma, but not B-cell lymphoblastoid or T-cell lymphoma cell lines

I. Kholodnyuk
, Z. Rudevica
, M. Cistjakovs
, S. Kozireva
, G. Norstedt
, A. Leonciks

Institute of Microbiology and Virology

Research output: Contribution to conference › Abstract › peer-review

209 Downloads (Pure)

Original language	English
Number of pages	1
Publication status	Published - 24 Jun 2017
Event	2nd Special Conference: The Challenges of Optimising Immuno and Targeted Therapies. From Cancer Biology to the Clinic. - Florence, Italy Duration: 24 Jun 2017 → 27 Jun 2017 Conference number: 2 https://www.aacr.org/wp-content/uploads/2020/01/EACR_AACR_SIC_Abstract_Titles_Program.pdf

Conference

Conference	2nd Special Conference: The Challenges of Optimising Immuno and Targeted Therapies. From Cancer Biology to the Clinic.
Abbreviated title	EACR-AACR-SIC 2017
Country/Territory	Italy
City	Florence
Period	24/06/17 → 27/06/17
Internet address	https://www.aacr.org/wp-content/uploads/2020/01/EACR_AACR_SIC_Abstract_Titles_Program.pdf

Field of Science*

1.6 Biological sciences
3.1 Basic medicine

Publication Type*

3.4. Other publications in conference proceedings (including local)

Access to Document

EACRAACRSIC 2017 Proceedings BookFinal published version, 2.78 MB

https://www.cancerologia.it/assets/2017_firenze_definitivo.pdf

Cite this

Kholodnyuk, I., Rudevica, Z., Cistjakovs, M., Kozireva, S., Norstedt, G., & Leonciks, A. (2017). Nucleotide-modified RNA-aptamer inhibits in vitro cell-proliferation of Burkitt lymphoma, but not B-cell lymphoblastoid or T-cell lymphoma cell lines. Abstract from 2nd Special Conference: The Challenges of Optimising Immuno and Targeted Therapies. From Cancer Biology to the Clinic. , Florence, Italy. https://www.cancerologia.it/assets/2017_firenze_definitivo.pdf

@conference{321a6c4c2baa421681523511c061f6ed,

title = "Nucleotide-modified RNA-aptamer inhibits in vitro cell-proliferation of Burkitt lymphoma, but not B-cell lymphoblastoid or T-cell lymphoma cell lines",

author = "I. Kholodnyuk and Z. Rudevica and M. Cistjakovs and S. Kozireva and G. Norstedt and A. Leonciks",

year = "2017",

month = jun,

day = "24",

language = "English",

note = "2nd Special Conference: The Challenges of Optimising Immuno and Targeted Therapies. From Cancer Biology to the Clinic. , EACR-AACR-SIC 2017 ; Conference date: 24-06-2017 Through 27-06-2017",

url = "https://www.aacr.org/wp-content/uploads/2020/01/EACR\_AACR\_SIC\_Abstract\_Titles\_Program.pdf",

}

Kholodnyuk, I, Rudevica, Z, Cistjakovs, M , Kozireva, S, Norstedt, G & Leonciks, A 2017, 'Nucleotide-modified RNA-aptamer inhibits in vitro cell-proliferation of Burkitt lymphoma, but not B-cell lymphoblastoid or T-cell lymphoma cell lines', 2nd Special Conference: The Challenges of Optimising Immuno and Targeted Therapies. From Cancer Biology to the Clinic. , Florence, Italy, 24/06/17 - 27/06/17. <https://www.cancerologia.it/assets/2017_firenze_definitivo.pdf>

Nucleotide-modified RNA-aptamer inhibits in vitro cell-proliferation of Burkitt lymphoma, but not B-cell lymphoblastoid or T-cell lymphoma cell lines. / Kholodnyuk, I.; Rudevica, Z.; Cistjakovs, M. et al.
2017. Abstract from 2nd Special Conference: The Challenges of Optimising Immuno and Targeted Therapies. From Cancer Biology to the Clinic. , Florence, Italy.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - Nucleotide-modified RNA-aptamer inhibits in vitro cell-proliferation of Burkitt lymphoma, but not B-cell lymphoblastoid or T-cell lymphoma cell lines

AU - Kholodnyuk, I.

AU - Rudevica, Z.

AU - Cistjakovs, M.

AU - Kozireva, S.

AU - Norstedt, G.

AU - Leonciks, A.

N1 - Conference code: 2

PY - 2017/6/24

Y1 - 2017/6/24

UR - https://www.aacr.org/wp-content/uploads/2020/01/EACR_AACR_SIC_Abstract_Titles_Program.pdf

M3 - Abstract

T2 - 2nd Special Conference: The Challenges of Optimising Immuno and Targeted Therapies. From Cancer Biology to the Clinic.

Y2 - 24 June 2017 through 27 June 2017

ER -

Kholodnyuk I, Rudevica Z, Cistjakovs M , Kozireva S, Norstedt G, Leonciks A. Nucleotide-modified RNA-aptamer inhibits in vitro cell-proliferation of Burkitt lymphoma, but not B-cell lymphoblastoid or T-cell lymphoma cell lines. 2017. Abstract from 2nd Special Conference: The Challenges of Optimising Immuno and Targeted Therapies. From Cancer Biology to the Clinic. , Florence, Italy.

Nucleotide-modified RNA-aptamer inhibits in vitro cell-proliferation of Burkitt lymphoma, but not B-cell lymphoblastoid or T-cell lymphoma cell lines

Conference

Field of Science*

Publication Type*

Access to Document

Other files and links

Cite this